About Us
Direct Access to Expert Insight in Neurology
Mission: Delivering quality and relevant information to healthcare professionals treating neurological diseases to help them achieve the best patient care possible.
Vision: NeurologyLive™ offers a print and digital media platform to busy healthcare professionals treating neurological diseases to deliver practice-changing news and insight directly from top medical conferences and researchers.
The platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive™ platform connects visitors with the most up-to-date clinical trial results, FDA approvals, practice-changing research, and expert insight.
Through a unique mix of video editorial, like the Peer Exchange platform, NeurologyLive™ offers dynamic discussions with authoritative insights, opinions, and perspectives on critical issues facing today's healthcare professionals. Expert insight is delivered across a variety of outlets, including print, web, video, social media, and email.
Visitors to NeurologyLive™ can rely on accurate and insightful coverage with expert insight of breaking FDA activity, including label revisions, submissions, and review process updates. Additionally, the platform provides insight into phase III findings, phase II results for high unmet needs, and novel clinical trials enrolling participants.
Through this information, NeurologyLive™ delivers direct access to expert insight to improve the lives of patients with neurological diseases, such as dementia or Alzheimer, epilepsy, headache or migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep medicine, and stroke.
Vision: NeurologyLive™ offers a print and digital media platform to busy healthcare professionals treating neurological diseases to deliver practice-changing news and insight directly from top medical conferences and researchers.
The platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive™ platform connects visitors with the most up-to-date clinical trial results, FDA approvals, practice-changing research, and expert insight.
Through a unique mix of video editorial, like the Peer Exchange platform, NeurologyLive™ offers dynamic discussions with authoritative insights, opinions, and perspectives on critical issues facing today's healthcare professionals. Expert insight is delivered across a variety of outlets, including print, web, video, social media, and email.
Visitors to NeurologyLive™ can rely on accurate and insightful coverage with expert insight of breaking FDA activity, including label revisions, submissions, and review process updates. Additionally, the platform provides insight into phase III findings, phase II results for high unmet needs, and novel clinical trials enrolling participants.
Through this information, NeurologyLive™ delivers direct access to expert insight to improve the lives of patients with neurological diseases, such as dementia or Alzheimer, epilepsy, headache or migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep medicine, and stroke.
Advertisement
Advertisement
Trending on NeurologyLive
1
Enhancing Gene Therapy Safety for Duchenne Through New Recommendations: Barry Byrne, MD, PhD
2
Expanding the Alzheimer Drug Development Pipeline
3
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
4
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
5